Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Strong Performer, Under Radar
862.2000 13.95 (1.64%)
NSE Sep 12, 2025 15:31 PM
Volume: 287.6K
 

logo
Natco Pharma Ltd.
14 Dec 2020, 12:00AM
862.20
1.64%
ICICI Securities Limited
Cipla: Owing to competition, we expect Cipla to garner 1-7% market share for volume-limited period and 15% thereafter. Hence, with above market share and a 70-90% price erosion assumption, our gRevlimid NPV arrives at | 41. We maintain BUY rating and arrive at a target price of | 965, including...
Number of MF schemes decreased from 54 to 47 in Jun 2025 qtr
More from Natco Pharma Ltd.
Recommended